Today we start a new series: Blog Spotlight. We put together a short list of excellent but somewhat overlooked blog that deserves a...
Read More
Retailing giant Wal-Mart announced a new program that will offer consumers $4 prescriptions for generic drugs (you can see the full list...
Read More
What do you think of the new Zune? That question led to fascinating discussion about Microsoft on Thursday. What they do, how they work,...
Read More
I am not a big fan of share buybacks. I have said in the past that my first priority would much rather be R&D versus a buyback; A...
Read More
One of the main Bullish arguments has been that very strong Earnings are not signalling a major slowdown. I find that argument...
Read More
From this week’s Barron’s, comes the latest bit of fiscal dishonesty from the White House: "THIS SPACE...
Read More
Okay, here’s the deal: In 2003, Ricky Gervais (The Office) and Stephen Merchant (his writing partner) made some hysterical training...
Read More
Google has a problem "most companies would love to confront: how to get better returns from investing its cash hoard without being...
Read More
In this weekend’s Linkfest, I referenced a Bloomberg article which looked at all the insider selling at Google and saw a total of...
Read More
Interesting article at Marketwatch advising you how to spot a Fund Manager that is not being forthcoming as to his performance. According...
Read More
